Læknablaðið : fylgirit - 05.01.2015, Síða 32

Læknablaðið : fylgirit - 05.01.2015, Síða 32
X V I I V Í S I N D A R Á Ð S T E F N A H Í F Y L G I R I T 8 2 32 LÆKNAblaðið/Fylgirit 82 2015/101 E 76 Rise in hypertensive disorders of pregnancy during the first year after a national economic collapse Védís H. Eiríksdóttir1, Unnur A. Valdimarsdóttir1,2, Tinna L. Ásgeirsdóttir3, Sigrún H. Lund1, Arna Hauksdóttir1, Helga Zoëga1 1Centre of Public Health Sciences, University of Iceland, 2Department of Epidemiology, Harvard School of Public Health, 3Department of Economics, University of Iceland vedis.helga@gmail.com Introduction: Previous research indicates that stress may play a role in the development of hypertensive disorders of pregnancy (HDP), including gestational hypertension (GH) and preeclampsia (PE). The 2008 Icelandic economic collapse represented a powerful stressor that caused increased level of stress among Icelandic women. The aim of the study was to assess whether the prevalence of HDP was elevated in the years following the economic collapse as compared with the years before the crisis. Methods and data: Women giving birth to live-born singletons in Iceland from 2005-2012 constitute the study population. Women‘s information of the use of antihypertensive drugs during pregnancy, including β-blockers and calcium channel blockers, was obtained from the Icelandic Medicines Registry. We used logistic regression analysis to estimate adjusted odds ratios (aOR) and corresponding 95% confidence intervals (CI) of HDP and redemption of antihypertensives by exposure to calendar time of the economic collapse, adjusting for aggregate economic indicators. Results: Compared with preceding years, we observed an increased odds of GH in the first year following the economic collapse (aOR=1.47, 95% CI [1.13-1.91]). Similarly, there was an increase in redemption of β-blockers in the first year following the collapse (aOR=1.43, 95% CI [1.07-1.90]). The observed associations attenuated when adjusting for aggregate unemployment rate (aOR=1.04, 95% CI [0.74-1.47]). No changes were observed for PE or calcium channel blockers. Conclusions: The results suggest an increase in GH and in redemption of β-blockers in the first year following the collapse. This increase may be explained by an increase in the national unemployment rate. E 77 Cognitive function in MS and its relation with physical ability, fatigue and depression Sólveig Jónsdóttir¹,², Hilmar P. Sigurðsson¹, Haukur Hjaltason¹,², Sóley Þráinsdóttir¹,² ¹Department of Neurology, Landspítali University Hospital, ²Faculty of Medicine, University of Iceland soljonsd@landspitali.is Introduction: Cognitive impairment is believed to affect approximately half of patients with multiple sclerosis (MS). The objective of this study was to evaluate cognitive function and its association with physical abi- lity, gender, fatigue and depression in Icelandic patients with relapsing remitting multiple sclerosis (RRMS). Methods and data: A total of 64 RRMS patients about to undergo treat- ment with natalizumab (Tysabri) and 24 sex- and age-matched healthy controls (HCs) participated in the study. Physical ability of patients was evaluated using the Expanded Disability Status Scale (EDSS). All participants underwent an extensive neuropsychological evaluation. Fatigue and depression in patients was also assessed. Results: The RRMS patients scored significantly lower than HCs on most cognitive domains. Greatest deficits were observed on psycho- motor speed. Verbal and visuospatial learning and memory, verbal and visuospatial fluency and linguistic skills were also impaired. Visuospatial reasoning ability was spared. The EDSS score (mean 3.5) was significantly related to cognitive measures that did not require any physical ability. When controlling for hand dexterity, approximately 53% of the patients were considered cognitively impaired. Males were more impaired than females. Severe fatigue was experienced by 81.3% of the patients and 45.3% suffered from depression. Fatigue and depress- ion had no effect on cognitive function. Conclusions: Impaired cognitive function can have serious effects on the quality of life and employability of RRMS patients and needs to be detected early in the disease process as it may affect treatment decisions. More studies are needed on methods to improve cognitive function and prevent further decline in patients with RRMS. E 78 Parental longevity and survival in patients with multiple myeloma and MGUS Ingigerður Sólveig Sverrisdóttir1, Sigrún Helga Lund2, Sigurður Yngvi Kristinsson3,4 1Landspítali University Hospital, 2Department of Public Health, Faculty of Medicine, University of Iceland, 3Faculty of Medicine, University of Iceland, 4Department of Hematology, Landspítali University Hospital ingigerdursverrisdottir@gmail.com Introduction: In the general population, parental longevity is associated with an increased life expectancy. There are limited data focusing on host characteristics and their effect on survival among multiple mye- loma (MM) patients and its precursor, MGUS. Our aim was to study the impact of parental longevity on survival among MM and MGUS patients. Methods and data: A total of 1,815 patients with MM, 1,407 MGUS patients as well as 8,267 population-based controls for MM patients and 5,595 controls for MGUS were included in the study. We compared the risk of death among MM and MGUS patients with a history of parental longevity to those patients without a long-lived parent. Results: Among MM patients, a history of parental longevity was not associated with a decreased risk of death (HR=0.92; 95% CI 0.81-1.05). Having one long-lived parent or both did not have an effect (HR=0.91; 95% CI 0.80-1.04 and HR=1.02; 95% CI 0.72-1.47, respectively). A history of parental longevity among MGUS patients was associated with a significant decrease in risk of death (HR=0.69; 95% CI 0.53-0.91). The risk of death decreased when one parent was long-lived (HR=0.69; 95% CI 0.52-0.91). However, based on few numbers, when both parents were long-lived the risk of death was not significantly affected (HR=0.72; 95% CI 0.34-1.53). Conclusions: Parental longevity does not predict survival in MM patients. For MGUS patients, however, the impact of longevity is similar to controls, with superior survival among those with long-lived parents. E 79 Prediagnostic serum 25 hydroxyvitamin D and total mortality of men diagnosed with prostate cancer Jóhanna Eyrún Torfadóttir1,2, Laufey Steingrímsdóttir2, Thor Aspelund1,4, Laufey Tryggvadóttir5, Þórhallur I. Halldórsson2, Vilmundur Guðnason 4,6 Unnur A. Valdimarsdóttir1,3 1Centre of Public Health Sciences, Faculty of Medicine, University of Iceland, 2Unit for Nutrition Research, Faculty for Food Science and Nutrition, University of Iceland, 3Department of Epidemiology, Harvard School of Public Health, 4The Icelandic Heart Association, 5The Icelandic Cancer Registry, 6Faculty of Medicine, University of Iceland jet@hi.is Introduction: Limited data are available on the effect of vitamin D
Síða 1
Síða 2
Síða 3
Síða 4
Síða 5
Síða 6
Síða 7
Síða 8
Síða 9
Síða 10
Síða 11
Síða 12
Síða 13
Síða 14
Síða 15
Síða 16
Síða 17
Síða 18
Síða 19
Síða 20
Síða 21
Síða 22
Síða 23
Síða 24
Síða 25
Síða 26
Síða 27
Síða 28
Síða 29
Síða 30
Síða 31
Síða 32
Síða 33
Síða 34
Síða 35
Síða 36
Síða 37
Síða 38
Síða 39
Síða 40
Síða 41
Síða 42
Síða 43
Síða 44
Síða 45
Síða 46
Síða 47
Síða 48
Síða 49
Síða 50
Síða 51
Síða 52
Síða 53
Síða 54
Síða 55
Síða 56
Síða 57
Síða 58
Síða 59
Síða 60
Síða 61
Síða 62
Síða 63
Síða 64
Síða 65
Síða 66
Síða 67
Síða 68
Síða 69
Síða 70
Síða 71
Síða 72
Síða 73
Síða 74
Síða 75
Síða 76
Síða 77
Síða 78
Síða 79
Síða 80
Síða 81
Síða 82
Síða 83
Síða 84
Síða 85
Síða 86
Síða 87
Síða 88
Síða 89
Síða 90
Síða 91
Síða 92
Síða 93
Síða 94
Síða 95
Síða 96
Síða 97
Síða 98
Síða 99
Síða 100
Síða 101
Síða 102
Síða 103
Síða 104
Síða 105
Síða 106
Síða 107
Síða 108
Síða 109
Síða 110
Síða 111
Síða 112
Síða 113
Síða 114
Síða 115
Síða 116
Síða 117
Síða 118
Síða 119
Síða 120
Síða 121
Síða 122
Síða 123
Síða 124
Síða 125
Síða 126
Síða 127
Síða 128
Síða 129
Síða 130
Síða 131
Síða 132
Síða 133
Síða 134
Síða 135
Síða 136
Síða 137
Síða 138
Síða 139
Síða 140
Síða 141
Síða 142
Síða 143
Síða 144
Síða 145
Síða 146
Síða 147
Síða 148
Síða 149
Síða 150
Síða 151
Síða 152
Síða 153
Síða 154
Síða 155
Síða 156
Síða 157
Síða 158
Síða 159
Síða 160
Síða 161
Síða 162
Síða 163
Síða 164
Síða 165
Síða 166
Síða 167
Síða 168
Síða 169
Síða 170
Síða 171
Síða 172
Síða 173

x

Læknablaðið : fylgirit

Beinleiðis leinki

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið : fylgirit
https://timarit.is/publication/991

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.